XML 24 R17.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Stock-Based Compensation | 3 Months Ended
--- | ---
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Stock-Based Compensation | 9. Stock-Based Compensation Stock Incentive Plan In March 2017, the Company’s stockholders approved the 2017 Stock Option and Grant Plan (the 2017 Plan), under which stock options and restricted stock awards were granted to eligible employees, officers, directors, consultants, or other key persons who provide services to the Company. Such issuances under the 2017 Plan were subject to vesting, forfeiture and other restrictions as deemed appropriate by the board of directors at the time of issuance. In August 2021, the Company's stockholders approved the 2021 Plan under which stock options, restricted stock units and other equity-based awards or any combination of these may be granted to eligible employees, officers, directors, consultants, or other key persons who provide services to the Company. Such issuances are subject to vesting, forfeiture and other restrictions as deemed appropriate by the board of directors at the time of issuance. As of March 31, 2024, the Company had 6,731,840 shares available for future issuance under the 2021 Plan. The 2023 Inducement Plan (the Inducement Plan) became effective upon approval of the Company's board of directors in February 2023. The Inducement Plan allows the Company to make equity and equity-based incentive awards to individuals who were not previously employees or directors of the Company. As of March 31, 2024, the Company had 2,057,750 shares available for future issuance under the Inducement Plan. The Company recorded stock-based compensation expense in the following expense categories in its accompanying condensed consolidated statements of operations:
|  | Three Months Ended March 31, |
|  | 2024 |  |  | 2023 |
|  | (in thousands) |
Research and development |  | $ | 3,806 |  |  | $ | 2,135 |
General and administrative |  |  | 2,913 |  |  |  | 2,084 |
Total |  | $ | 6,719 |  |  | $ | 4,219 |
Stock Option Activity The following table summarizes the stock option activity for the three months ended March 31, 2024:
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Contractual Term |  |  | Aggregate Intrinsic Value |
|  |  |  |  |  |  |  | (in years) |  |  |  |
Options outstanding as of December 31, 2023 |  |  | 16,734,960 |  |  | $ | 6.21 |  |  |  | 7.83 |  |  | $ | 62,640,906 |
Granted |  |  | 4,288,631 |  |  | $ | 12.12 |  |  |  |  |  |  |
Exercised |  |  | (333,511 | ) |  | $ | 3.81 |  |  |  |  |  |  |
Cancelled |  |  | (100,855 | ) |  | $ | 7.14 |  |  |  |  |  |  |
Options outstanding as of March 31, 2024 |  |  | 20,589,225 |  |  | $ | 7.47 |  |  |  | 8.00 |  |  | $ | 37,007,114 |
Options exercisable as of March 31, 2024 |  |  | 9,348,930 |  |  | $ | 5.95 |  |  |  | 7.04 |  |  | $ | 24,344,914 |
As of March 31, 2024, total unrecognized compensation expense related to stock options was $63.6 million, which the Company expects to recognize over a remaining weighted-average period of 2.7 years. Restricted Stock Unit Activity The following table summarizes the RSU activity for the three months ended March 31, 2024:
|  | Number of Stock Units |  |  | Weighted Average Grant Date Fair Value Per Share |
Unvested and outstanding as of December 31, 2023 |  |  | 757,514 |  |  | $ | 5.25 |
Granted |  |  | 709,718 |  |  |  | 12.14 |
Vested |  |  | (197,925 | ) |  |  | 5.18 |
Forfeited |  |  | (14,851 | ) |  |  | 6.24 |
Unvested and outstanding as of March 31, 2024 |  |  | 1,254,456 |  |  | $ | 9.15 |
As of March 31, 2024, total unrecognized compensation expense related to RSUs was $10.7 million, which the Company expects to recognize over a remaining weighted-average period of 2.4 years. 2021 Employee Stock Purchase Plan The 2021 Employee Stock Purchase Plan (the 2021 ESPP) was adopted and approved by the Company’s board of directors and by the Company’s stockholders and became effective upon the closing of the Business Combination. During the three months ended March 31, 2024, the Company issued zero shares of co mmon stock under the 2021 ESPP.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration